Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 9, Issue 10, Pages 1429-1434
Publisher
Informa UK Limited
Online
2009-10-15
DOI
10.1586/era.09.96
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted therapies in metastatic renal cancer in 2009
- (2009) Laurence Bastien et al. BJU INTERNATIONAL
- Metastatic renal cell cancer treatments: An indirect comparison meta-analysis
- (2009) Edward J Mills et al. BMC CANCER
- 252 RETROSPECTIVE ANALYSIS OF THE SEQUENTIAL USE OF SORAFENIB AND SUNITINIB IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC)
- (2009) C. Porta et al. EUROPEAN UROLOGY SUPPLEMENTS
- Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
- (2009) Axel Hauschild et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma
- (2009) Kenneth L. Hill et al. JOURNAL OF NEUROSURGERY
- Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
- (2009) M.P. Sablin et al. JOURNAL OF UROLOGY
- Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib
- (2009) Kaja Zimmermann et al. ONCOLOGY
- Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
- (2008) Arkadiusz Z. Dudek et al. CANCER
- A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer
- (2008) W. L. Dahut et al. CLINICAL CANCER RESEARCH
- The medical treatment of metastatic renal cell cancer in the elderly: Position paper of a SIOG Taskforce
- (2008) Joaquim Bellmunt et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Targeting Angiogenesis in Renal Cell Carcinoma
- (2008) Georgios Lainakis et al. CURRENT CANCER DRUG TARGETS
- Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis
- (2008) Christian Eichelberg et al. EUROPEAN UROLOGY
- Successful Sorafenib Treatment for Metastatic Renal Cell Carcinoma in a Case with Chronic Renal Failure
- (2008) Sebastian Ruppin et al. EUROPEAN UROLOGY
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma
- (2008) Francesca Valcamonico et al. JOURNAL OF NEURO-ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Comparison of Sorafenib and Sunitinib for Second-Line Treatment of Cytokine-Refractory Kidney Cancer Patients
- (2008) Edwin Herrmann et al. ONCOLOGY
- Les anti-angiogéniques : de nouveaux standards thérapeutiques dans le cancer du rein métastatique
- (2008) J.-N. Cornu et al. PROGRES EN UROLOGIE
- An update on the medical therapy of advanced metastatic renal cell carcinoma
- (2008) Stephan Kruck et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- Der Stellenwert der Targeted-Therapie beim Nierenzellkarzinom
- (2008) A.S. Merseburger et al. UROLOGE
- Targeted therapy in renal cell carcinoma
- (2008) Jean-Jacques Patard et al. WORLD JOURNAL OF UROLOGY
- Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma
- (2007) Naeem Bhojani et al. EUROPEAN UROLOGY
- Antitumor Effects of Sunitinib or Sorafenib in Patients With Metastatic Renal Cell Carcinoma Who Received Prior Antiangiogenic Therapy
- (2007) Ila Tamaskar et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now